| Date | Title | Description |
| 17.03.2026 | Metabolon Collaborates with The Michael J. Fox Foundation to Advance Multiomic Analyses for Parkinson's Research | Partnership supports expanded biomarker discovery efforts within MJFF's Parkinson's Progression Markers Initiative
MORRISVILLE, N.C., March 17, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions adva... |
| 17.02.2026 | Metabolon's Metabolomics Platform Enables Largest Metabolomic Analysis to Date in CAR T-Cell Therapy, Revealing New Insights into Severe Neurotoxicity | Metabolomics-Derived Pathway Scores Outperform Inflammatory Protein Markers—Delivering Risk Prediction Where Proteomics Falls Short
MORRISVILLE, N.C., Feb. 17, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomic... |
| 03.02.2026 | Metabolon Names Andrew Messick Chief Financial Officer | Seasoned life sciences finance leader brings deep expertise in operational excellence and M&A to support Metabolon's next stage of growth
MORRISVILLE, N.C., Feb. 3, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing me... |
| 14.01.2026 | Metabolon Appoints Celia Reyes as Vice President of Human Resources | Celia Reyes will lead Metabolon's global people strategy as the company continues to scale in the evolving multiomics marketplace
MORRISVILLE, N.C., Jan. 14, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics ... |
| 04.11.2025 | Metabolon Powers Largest-Ever Veteran Metabolomics Study with Global Discovery Panel | Metabolon to Support Landmark Million Veteran Program 62,000-sample Dataset Advancing Veteran Health and Multiomics Research
MORRISVILLE, N.C., Nov. 4, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics soluti... |
| 07.10.2025 | Metabolon's Metabolomics Services Now Cited in More Than 4,000 Peer-Reviewed Publications | Metabolon's best-in-class metabolomics leadership accelerates as metabolomics becomes a standard inclusion in global multiomics studies
MORRISVILLE, N.C., Oct. 7, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolo... |
| 09.09.2025 | Metabolon Partners with China Kadoorie Biobank to Advance Precision Health | The landmark multiomics study will examine how lifestyle, environmental, socioeconomic, and genetic factors play a significant role in shaping common diseases
MORRISVILLE, N.C., Sept. 9, 2025 /PRNewswire/ -- Metabolon, Inc., the global lead... |
| 08.07.2025 | Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science | A recognized pioneer in metabolomics, Metabolon is the most experienced and trusted metabolomics partner in the life sciences industry
MORRISVILLE, N.C., July 8, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolom... |
| 01.07.2025 | Metabolon's Untargeted Metabolomics Services Used for Breakthrough Study Revealing Powerful Link Between Gut Microbiome, the Metabolome, and Type 2 Diabetes (T2D) | Combining metabolomics, gut microbiome, and clinical data may help prevent and personalize the treatment of type 2 diabetes
MORRISVILLE, N.C., July 1, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutio... |
| 28.05.2025 | Metabolon's Untargeted Metabolomics Services Used for Landmark Study Linking a Western Dietary Pattern During Pregnancy to Neurodevelopment Disorders | Metabolomic profiling uncovered how maternal diet and metabolism may contribute to the risk of ADHD and autism in children
MORRISVILLE, N.C., May 28, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solution... |
| 29.04.2025 | Metabolon Launches Microbiome Research Solution Combining New Microbiome Panel, Metagenomics Sequencing, and Multiomics Bioinformatics Tools | The combination of metagenomics and metabolomics data, integrated within an intuitive bioinformatics platform, enables deeper microbiome insights than possible with either approach individually
MORRISVILLE, N.C., April 29, 2025 /PRNewswire/... |
| 27.02.2025 | Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its Industry-leading Integrated Bioinformatics Platform | Metabolon's expertise extends beyond metabolomics to include data insights and software solutions for multiomics research
MORRISVILLE, N.C., Feb. 27, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solution... |
| 14.01.2025 | Metabolon Appoints Michael Irwin as Vice President, Global Head of Sales | Michael Irwin will drive Metabolon's global sales strategy as the company moves into its next phase of growth in the mutliomic marketplace
MORRISVILLE, N.C., Jan. 14, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing meta... |
| 12.11.2024 | Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders | Ground-breaking investigation leverages Metabolon's Global Discovery Panel for metabolite genome-wide association study (MGWAS) for cerebrospinal fluid (CSF) and brain metabolite levels as they pertain to neurodegenerative disorders
MORRISV... |
| 14.10.2024 | Metabolon Launches New "Guide to Multiomics" and Accompanying Multiomics Webinar | Metabolon's new multiomics guide and webinar demystify complex omics technologies and illuminate how integrated multiomics is transforming life science research
MORRISVILLE, N.C., Oct. 14, 2024 /PRNewswire/ -- Metabolon, Inc., the global le... |
| 17.09.2024 | Metabolon Expands Integrated Bioinformatics Platform to Include Advanced Statistical Analysis Tool | New tool plays a critical role in supporting complex multiomic research initiatives by helping scientists design and execute customized statistical analyses
MORRISVILLE, N.C., Sept. 17, 2024 /PRNewswire/ -- Metabolon, Inc., the global leade... |
| 28.08.2024 | Metabolon and the Scottish Early Rheumatoid Arthritis (SERA) Study Announce Partnership to Leverage Metabolomics Data to Better Understand the Molecular Mechanisms of Rheumatoid Arthritis | Partnership seeks to identify rheumatoid arthritis biomarkers to improve understanding of disease risk, progression, and treatment responses
MORRISVILLE, N.C. and GLASGOW, Scotland, Aug. 28, 2024 /PRNewswire/ -- Metabolon, Inc., the global ... |
| 16.07.2024 | Metabolon Expands Library to Include 70 Pesticides, Advancing Human Exposome Insights through Metabolomics | MORRISVILLE, N.C., July 16, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applicati... |
| 13.07.2024 | Swedish diagnostics firm Immunovia moving US HQ from Boston to Durham | A Swedish cancer diagnostics developer is reinventing itself and transplanting its North American headquarters from the Boston area to North Carolina’s booming Research Triangle area to become more efficient and effective.
Immunovia said in... |
| 25.06.2024 | Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression | MORRISVILLE, N.C., June 25, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applicati... |
| 30.05.2024 | Metabolon Announces 4-Week Turnaround Time for Commercial Projects, Enhancing Metabolomic Services for Multiomic Research | MORRISVILLE, N.C., May 30, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applicatio... |
| 28.05.2024 | Metabolon Now Includes Spectral Data Files for All Global Discovery Panel Projects | MORRISVILLE, N.C., May 28, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applicatio... |
| 17.05.2024 | Metabolon's $60M Credit Facility: Fueling Growth and Innovation in Metabolomics | Metabolon, a renowned company based in Morrisville, NC, specializing in providing metabolomics solutions for life science research, diagnostic, therapeutic development, and precision medicine applications, recently secured a substantial $60... |
| 17.05.2024 | Metabolon secures $60M credit facility to fund growth | Morrisville-based Metabolon, a provider of metabolomics data and insights for the life sciences, has closed on a new $60 million credit facility to fund company growth and expand research and development efforts.
An initial $42.5 million wa... |
| 16.05.2024 | Metabolon Secures $60M Credit Facility | Metabolon, a Morrisville, NC-based company which specialises in providing metabolomics solutions for life science research, diagnostic, therapeutic development, and precision medicine applications, received a $60M credit facility.
Trinity C... |
| 20.11.2023 | Metabolon Collaborates with Trajan on Microsampling Solutions for Metabolomics Research | The power of advanced metabolomic analytical techniques can now be applied to a broader array of diverse academic and commercial life science research
MORRISVILLE, N.C. and TORRANCE, Calif., Nov. 20, 2023 /PRNewswire/ -- Metabolon, Inc., th... |
| 25.01.2023 | Metabolon Raises $25M in Funding | Metabolon, a Morrisville, NC-based provider of metabolomics solutions that offers variety of research, diagnostic, therapeutic development, and precision medicine applications, raised $25M in funding.
The backers were not disclosed.
The com... |
| 24.01.2023 | Metabolon Secures $25 Million of Funding to Accelerate Growth | MORRISVILLE, N.C, Jan. 24, 2023 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of research, diagnostic, therapeutic development, and precision medicine applications, today ... |
| 24.01.2023 | Metabolon Secures $25M |
MORRISVILLE, NC, Metabolon today announced that it has closed on $25 million of additional equity funding.
>> Click here for more funding data on Metabolon
>> To export Metabolon funding data to PDF and Excel, click here
... |
| 26.10.2021 | Demystifying the Microbiome: Connecting Metabolomics to Health and Drug Response, Upcoming Webinar Hosted by Xtalks | The unique capability of metabolomics to measure microbiome-derived metabolites sheds light on the biological activity of bacterial communities in ways that other omics technologies cannot.
TORONTO (PRWEB) October 26, 2021
Most microbes in ... |
| 23.09.2020 | Metabolon Announces $72 Million in Debt and Equity Financing | Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precision medicine, today announced the close on $72 million in combined debt and equity financing. This round of financing included Perceptive Advi... |
| 23.09.2020 | Metabolon Closes $72 Million in Debt and Equity Financing | Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precision medicine, today announced the close on $72 million in combined debt and equity financing. This round of financing included Perceptive Advi... |
| 23.09.2020 | Metabolon, Inc. : Announces $72 Million in Debt and Equity Financing to Accelerate Advancements in Precision Medicine and Innovative Drug Development Technologies | MORRISVILLE, N.C., Sept. 23, 2020 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solutions advancing drug development and precision medicine, today announced the close on $72 million in combined debt and equity financing... |
| 11.10.2019 | Zosano Pharma CEO passes baton down to successor; James Sapirstein takes the helm at AzurRx | Steven Lo
→ Two years after Zosano Pharma reported positive Phase III data for its microneedle patch system for delivering an old migraine drug — setting up a campaign to file an NDA — the company has brought on Steven Lo ... |
| 08.12.2016 | Metabolon Raises Additional $15M |
RESEARCH TRIANGLE PARK, NC, Global leader in metabolomics, announced today that it has raised an additional $15 million in funding from investor Essex Woodlands.
>> Click here for more funding data on Metabolon
>> To export ... |
| 07.12.2016 | Term Sheet — Wednesday, December 7 | ET CETERA
• Adroll has laid off around 50 employees. AdRoll CEO Aaron Bell provided the following statement to Term Sheet:
Paid Content You can't secure what you can't see From ExtraHop
The San Francisco ad-tech company has raised $90 milli... |
| 06.12.2016 | Metabolon Raises Additional $15M in Funding | Metabolon, Inc., a Research Triangle Park, N.C.-based health technology company, raised an additional $15 million in funding.
Essex Woodlands, a healthcare growth equity firm, made the investment, which added to an initial $15m investment i... |
| 05.12.2016 | Metabolon Raises Additional $15 Million in Funding from Essex Woodlands | Dec 05 2016
RESEARCH TRIANGLE PARK, N.C. – – Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding from investor Essex Woodlands, a leading healthcare growth equity firm... |
| 05.12.2016 | Metabolon Raises Additional $15 Million in Funding From Essex Woodlands | RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, announced today that it has raised an additional $15 million in funding from investor Essex Woodlands, a leading healthcare ... |
| 15.10.2016 | Beyond Theranos: Next options for a better blood draw | Theranos, once Silicon Valley’s sexiest startup, recently announced plans to shut down its blood-test facilities and lay off almost half its workers.
But that shouldn’t mean the premise of Theranos is flawed. In fact, CEO Elizabeth Holmes’ ... |
| 12.08.2016 | Precision Medicine Company Metabolon Closes $15M Financing | Metabolon, Inc., a Research Triangle Park, N.C. – based global leader in metabolomics, raised $15m in funding.
Essex Woodlands, a healthcare growth equity firm, made the investment. Metabolon and Essex Woodlands have the ability to increase... |
| 11.08.2016 | Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities | Aug 11 2016
RESEARCH TRIANGLE PARK, N.C. –– Metabolon, Inc., the global leader in metabolomics, announced today that it has closed a financing that raised $15 million from new investor Essex Woodlands, a leading healthcare growth equity fi... |
| 07.07.2015 | Morning Read: BioCardia files IPO with hopes of $50M, HHS seeks to protect health of children crossing the border | In response to the influx of Central American children immigrating to the U.S. over the last year, the Department of Health and Human Services (HHS) says it has increased the number of doctors available to treat these unaccompanied minors a... |
| 12.03.2015 | Metabolon raises $5M for tech that can determine how individuals will metabolize drugs | It is backed by roughly $50 million in private funding, including from Aurora Funds Inc., Fletcher Spaght Ventures LP, Syngenta Ventures, Sevin Rosen Funds, Harris & Harris Group Inc. and Keating Capital Inc.
This new round is the lates... |
| 06.01.2014 | Metabolon Raises $15M in Series E Financing | Metabolon, Inc., a Durham, NC-based provider of metabolomics-based diagnostic tests and research services, raised $15m in Series E financing.
The round was led by new investor Camden Partners with participation from Sumitomo Corporation and... |
| 18.04.2012 | Takeda partners with Metabolon to find biomarkers for pharma R&D | Metabolon’s platform technology discovers biomarkers, chemical signatures that indicate disease. Identifying biomarkers and finding the corresponding metabloic pathways can speed drug discovery and development. Finding these biomarkers also... |
| 12.04.2012 | Personalized medicine: A long path, uncertain directions and distant goals | If personalized medicine’s promise isn’t easily understood, Dr. Kristin Newby can readily explain it through her clinical practice.
The cardiologist at the Duke University Medical Center in Durham, North Carolina routinely sees patients who... |
| 15.02.2012 | Pharmas, medical device makers set to pitch at CED Life Science conference | A total of 16 companies are scheduled to make presentations, split evenly between pharmaceuticals and medical devices. Here’s a quick rundown of the presenting companies, all of whom are either based in North Carolina’s Research Triangle or... |
| 30.08.2011 | Metabolon Inks $13.1M Series D |
New investor Keating Capital, Inc. joins existing investors including Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght and Fulcrum Financial Partners in the round.
>> Click here for mor... |
| 29.08.2011 | Metabolon Secures $13.1M in Series D Financing | Metabolon, Inc., a Durham, NC-based diagnostics and services company offering a biochemical profiling technology, has secured $13.1m in a Series D financing.
New investor Keating Capital, Inc. has joined existing investors including Sevin R... |
| 29.08.2011 | Diagnostics firm Metabolon raises $13M in series D; is IPO next? | “We’re very impressed with Metabolon’s disruptive technology and commercial success,” Keating Capital CEO Timothy Keating said in a prepared statement. “Its diagnostic portfolio is targeting disease areas where there is a significant unmet ... |
| - | Metabolon Raises $60 Million In Growth Capital From Trinity Capital | Trinity Capital, a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $60 million in growth capital to Metabolon – a global leader in providing metabolomics solutions advancing a wide ... |
| - | Diagnostics firm Metabolon raises $13M in series D; is IPO next? | Diagnostics firm Metabolon has raised $13.1 million in a fourth round of financing and in doing so has signaled intentions to eventually pursue an initial public stock offering.
Metabolon added new investor Keating Capital, a a business dev... |
| - | Metabolon | “Metabolon uses metabolomics to provide biological insights to answer the toughest questions in life sciences research and drug development.” |
| - | Personalized medicine: A long path, uncertain directions and distant goals | If personalized medicine’s promise isn’t easily understood, Dr. Kristin Newby can readily explain it through her clinical practice.
The cardiologist at the Duke University Medical Center in Durham, North Carolina routinely sees patients who... |
| - | Metabolon | - |
| - | Pharmas, medical device makers set to pitch at CED Life Science conference | Life science companies and investors, let’s make a deal.
The annual CED Life Science Conference kicks off in Raleigh, North Carolina today where small drug developers hope to make the right connection with a big pharmaceutical company or ve... |
| - | Takeda partners with Metabolon to find biomarkers for pharma R&D | Takeda Pharmaceutical (TYO:4502) will use biochemical discovery technology from Metabolon to find new therapeutic targets and biomarkers.
No financial terms of the research alliance were disclosed. But Metabolon said that the Japanese pharm... |
| - | Metabolon raises $5M for tech that can determine how individuals will metabolize drugs | Metabolomics company Metabolon just raised about $5 million in equity from four investors, according to a recent regulatory filing. The metabolomics company plays in the precision medicine space, providing phenotyping tech that can, say, de... |
| - | Morning Read: BioCardia files IPO with hopes of $50M, HHS seeks to protect health of children crossing the border | TOP STORIES
BioCardia, which is expecting to enter its lead cell-based therapy for cardiovascular disease into a Phase 3 trial this year, has now filed paperwork indicating hopes to raise around $50 million in an IPO. – Xconomy
The Obama ad... |
